Related Experiment Video
Updated: May 22, 2026
05:34
Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods
Published on: June 6, 2025
Backtranslating clinical knowledge for use in cheminformatics--what is the potential?
1BioVariance, Garmischer Str. 4/V, 80339 Munich, Germany. mail@josef-scheiber.de
Bioorganic & Medicinal Chemistry
|May 26, 2012
Summary
Leveraging clinical data from marketed drugs (
Area of Science:
- Drug Discovery
- Cheminformatics
- Translational Medicine
Background:
- Current drug discovery prioritizes 'bench to bedside' approaches.
- The value of 'bedside to bench' data integration in early drug discovery is often underestimated.
- Clinical data from individual patients offers deep insights into drug efficacy and safety.
Purpose of the Study:
- To explore the application of clinical data in early-stage drug discovery.
- To demonstrate how 'bedside to bench' data can enhance cheminformatics analyses.
- To improve the design of drugs tailored for specific patient subpopulations.
Main Methods:
- Utilizing comprehensive clinical data associated with marketed drugs.
- Integrating clinical insights with chemical structure information.
- Applying cheminformatics analyses to leverage patient-level data.
Main Results:
- Gained deep insights by analyzing individual patient clinical data.
- Successfully combined clinical data with chemical structure information.
- Enhanced decision-making for medicinal chemists through data integration.
Conclusions:
- Clinical data, when analyzed from 'bedside to bench', significantly benefits early drug discovery.
- Cheminformatics applications are crucial for integrating diverse data types.
- This approach enables the development of precision medicines for well-defined subpopulations.
Related Concept Videos
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:29Primary Active Transport
In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction they would not...
01:44The Significance of Membrane Transport
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...